GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ABCB · Sep 30, 2025

Ameris Bancorp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000351569-25-000037Bank
Sequential deposit growth45thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

1.35% · CORE · VALID

Net-income growth40thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

6.87% · CORE · VALID

Interest-income growth25thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

-0.03% · CORE · VALID

Cash and equivalents5thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$1.0B · CORE · VALID

Sequential loan growth40thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

1.03% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History52 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
0.09%
Current
1.35%
Delta
1.25%
Earnings Growth Decreased
Previous
20.98%
Current
6.87%
Delta
-14.11%
Interest Income Growth Decreased
Previous
0.09%
Current
-0.03%
Delta
-0.12%
Liquidity Decreased
Previous
$1.2B
Current
$1.0B
Delta
-$127.1M
Loan Growth Decreased
Previous
1.66%
Current
1.03%
Delta
-0.63%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.